+15%
Additional synergies on operational costs
Life Sciences
Private Equity
Carve-out & Merger Integration
Operations Due Diligence
Transactions and Turnaround
Post-Merger Integration Exceeds Financial Targets for PE Fund
Integrated two pharmaceutical companies across five countries, delivering 15% operational cost synergies and 13% revenue growth.